featured
Improved Glycemic Variability and Time in Range With Dapagliflozin vs Gliclazide Modified-Release Among Adults With Type 2 Diabetes Evaluated by CGM
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Improved Glycemic Variability and Time in Range With Dapagliflozin Versus Gliclazide Modified Release Among Adults With Type 2 Diabetes Evaluated by Continuous Glucose Monitoring: A 12-week Randomized Controlled Trial
Diabetes Obes Metab 2019 Nov 10;[EPub Ahead of Print], AGD Vianna, CS Lacerda, LM Pechmann, MG Polesel, EC Marino, M Scharf, JM Detsch, K Marques, CP SanchesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.